Trial intelligence / Profile preview

Corabotase (IPN10200) in Adult Upper Limb Spasticity

NCT04752774Phase 2Recruiting

Sponsor
Ipsen
Start
Apr 2021
Primary completion
Mar 2029
Modality
Therapeutic Enzymes
Countries
14
01

Overview

A Phase 2 trial of corabotase in spasticity, sponsored by Ipsen. Started Apr 2021; status: recruiting.

02

Drugs

corabotase
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT04752774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04752774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call